Fundraising Fox
Anís
InvestorDirector, R&D Strategic Insights at Novartis Venture Fund · Head of Scoping, Pharma at Deep Science Ventures
London, England, United Kingdom
Find your path to Anís
269 people in our graph can introduce you to Anís.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Adam Cotton to introduce you to Anís
You →Adam · together at Novartis Venture Fund (2026) →Anís
Ask Jamie Chen to introduce you to Anís
You →Jamie · 7 people · together at Novartis Venture Fund →Anís
Ask Sam Okafor to introduce you to Anís
You →Sam · 3 people · together at UCB →Anís
Sign up to find every way you can get introduced to Anís
- Your email: the people you already email who know Anís
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Anís
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Biopharma researcher and former Clarendon Scholar with an Oxford PhD in breast-cancer single-cell genomics; helps build curative therapeutics companies at DSV.
Experience
- NovartisDirector, R&D Strategic Insightscurrent2026 — presentLondon, England, United Kingdom
- Kindling BioBoard Member2026London Area, United Kingdom
- Stealth Mode BiotechVP Biology & Program Lead2026Cambridge, England, United Kingdom
- Stealth Mode BiotechOrigination Lead2024 — 2025Cambridge, England, United Kingdom
- Flip TherapeuticsCo-Founder & Operating Partner | Board Observer2025 — 2026Cambridge, Massachusetts, United States
- Flip TherapeuticsOrigination Lead2023 — 2024Cambridge, Massachusetts, United States
- Deep Science VenturesPrincipal (Head of Scoping) — Pharmaceuticals2024 — 2026Greater London, England, United Kingdom
- Deep Science VenturesSenior Associate – Pharmaceuticals2022 — 2023Greater London, England, United Kingdom
- Deep Science VenturesAssociate – Pharmaceuticals2022Greater London, England, United Kingdom
- Deep Science VenturesAnalyst – Pharmaceuticals2020 — 2022Greater London, England, United Kingdom
- Deep Science VenturesFellow – Pharmaceuticals2020Greater London, England, United Kingdom
- Self-employedFreelance Consultant2025
- University of OxfordPhD Candidate & Clarendon Scholar – Kennedy Institute2017 — 2021
- University of OxfordMSc Candidate – Nuffield Department of Experimental Medicine2017
- UCBResearch Associate – Immunology Therapeutic Area2015 — 2016Slough, United Kingdom
- Boehringer IngelheimResearch Scientist Trainee – New Therapeutic Concepts (Oncology)2013 — 2014Vienna, Austria
- Lonza BiologicsAuditor – Quality Assurance2012Slough, United Kingdom
- Lonza BiologicsDocument Administrator – Quality Assurance2010 — 2011Slough, England, United Kingdom
Skills & more
Program ManagementLead OptimisationPre-clinical StudiesPharmacokineticsProtein EngineeringTechnology EvaluationProgram LeadershipIn-licensingCRO ManagementCorporate GovernanceBoard of DirectorsBoard of Directors Reporting
+12 more
Corporate FundraisingTerm SheetsConsultancy ServicesFreelancingConsultingStatisticsHigh Performance Computing (HPC)ProgrammingLeadershipTeam ManagementPlatform OperationsTranslational StrategyLanguages English · French · German
- Role of the Board Director (Training Course) — The Chartered Governance Institute UK & Ireland
- Personal Licence — UK Home Office
From Anís's professional profile.
Colleagues at Novartis Venture Fund
Adam Cotton
Principal at the Novartis Venture Fund
Anja Koenig
Global Head of NVF at Novartis Venture Fund
Anja König
Global Head at Novartis Venture Fund
Bart Dzikowski
Managing Director, Head of Transactions & Legal at Novartis Venture Fund
Beat Steffen
Managing Director at Novartis Venture Fund
Campbell Murray
Advisor
Christoph Meier
Investor at Novartis Venture Fund
Elaine Jones
Investor at Novartis Venture Fund
Frequently asked questions
- Who is Anís?
- Biopharma researcher and former Clarendon Scholar with an Oxford PhD in breast-cancer single-cell genomics; helps build curative therapeutics companies at DSV.
- Where does Anís work?
- Anís is Director, R&D Strategic Insights at Novartis Venture Fund.
- Where did Anís go to school?
- Anís studied at University of Oxford (Doctor of Philosophy (DPhil/PhD), Molecular and Cellular Medicine); University of Oxford (Master of Science (MSc), Integrated Immunology); The University of Manchester (Bachelor of Science (BSc) (Hons), Biochemistry with Industrial Experience).
Same school
Also attended University of Oxford1,756
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index VenturesJan HammerInvestor at Index Ventures
+ 1,750 more
Also attended The University of Manchester342
Joel NoyceInvestor at Moonfire VenturesJames BraithwaiteFinancial Controller at NorthzoneFreya Svedberg-KeatingInvestor at MedicxiAndy LeaverOperating Partner at Notion CapitalSimon SegarsExecutive Advisor at Black Opal VenturesHonor de WintonExecutive Assistant at Giant Ventures Global Llp
+ 336 more
Shared employers
Also worked at Kindling Bio1
Also worked at Deep Science Ventures39
Saran DaviesInvestor at Moonfire VenturesJustin BriggsScientist, entrepreneur, and investor building companies at the nexus of biology, chemistry, and engineeringFrank HicksImpact Committee at EcoEnterprises FundDomFounding Director at Deep Science VenturesSantaDirector, Talent at Deep Science VenturesAhmadExecutive Chairman at Deep Science Ventures
+ 33 more
Also worked at University of Oxford225
Tess van StekelenburgPartner at Lux CapitalGordon RausserAdvisory Board Member at Rembrandt Venture PartnersFrancesco MonacaInvestor at Giant Ventures Global LlpDenise XifaraInvestor at Mercuri.vcLirui DingPrincipal at TRANSCENDAna FernandezInvestment Associate at Nauta Capital
+ 219 more
